As a general rule, one thing you should definitely not do is start typing random symptoms you might be experiencing into Google Search, or, say, an AI chat box. If you’re concerned that something ...

Objective To evaluate the diagnostic accuracy of transthoracic echocardiography (TTE) in patients with pulmonary hypertension (PH). Design Systematic review and meta-analysis. Data sources and ...

Objective This study aims to evaluate the role of antiphospholipid antibodies (aPLs) in patients with SLE with heart valve ...

Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.

A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing death in those with more advanced disease.

Merrill H. Stewart, MD, Ochsner Health, explains how his practice takes advantage of downtime during cardiologist ...

A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing death in those with more advanced disease.

Liquidia announces FDA approval and commercial launch of YUTREPIA for treating pulmonary arterial hypertension and PH-ILD. Quiver AI Summary. Liquidia Corporation has announced that its inhalation ...

Patients with pulmonary hypertension associated with congenital heart disease make up an increasing proportion of the total pulmonary hypertension population ... Accurate measurements of RV function ...

The new research, published online April 5 in the American Heart Journal, shows that the virtual echocardiography screening tool (VEST), when incorporated into the electronic medical record (EMR ...

Three drug classes are FDA-approved for chronic treatment of WHO Group 1 PH (pulmonary arterial hypertension), whereas no drugs have been approved for Groups 2–5. Current Treatments ...